BRIACELL THERAPEUTICS CORP - COM NEW (BCTX)

CUSIP: 10778Y302

Q4 2023 13F Holders as of 31 Dec 2023

Share change
-1,582,150
SEC-reported price per share
$5.84
Number of holders
2
Value change
-$9,888,557
Number of buys
1
Number of sells
1

Security key

10778Y302

Report period

Q4 2023

Institutions

2

Top holders

2

Ownership snapshot

Top reported holders of BCTX - BRIACELL THERAPEUTICS CORP - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Lynwood Capital Managemen...
Disclosed value leader
Lynwood Capital Managemen...
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F 3/4/5 Highest disclosed value: $9,890,312 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Lynwood Capital Management Inc. has the largest disclosed position value at $9.89M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Lynwood Capital Management Inc.'s linked filing trail.
Disclosed position value Top 5
Lynwood Capital Management Inc. $9.89M
WASATCH ADVISORS LP $3.21M
Redmond Asset Management, LLC $1.04M
ARMISTICE CAPITAL, LLC $926.2K
Jamieson Bondarenko $777.9K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Lynwood Capital Management Inc.
13F
Company
13F
—
denominator unverified
$9,890,312
1,582,450 shares
— 30 Sep 2023
WASATCH ADVISORS LP
13F
Company
13F
—
denominator unverified
$3,211,006
513,761 shares
— 30 Sep 2023
Redmond Asset Management, LLC
13F
Company
13F
—
mixed-class rows
$1,041,494
212,839 shares
mixed-class rows
— 30 Sep 2023
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$926,250
375,000 shares
— 30 Sep 2023
Jamieson Bondarenko
3/4/5
Chairman, Director
—
denominator unverified
$777,940
169,856 shares
— 28 Dec 2022
NATIXIS
13F
Company
13F
—
denominator unverified
$597,381
95,581 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
312
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
2
Q4 2023 holders
2
Holder diff
0
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .